TAG:
accessioning
Ken Freeman Discusses Plans to Integrate AML and Unilab
By Robert Michel | From the Volume IX No. 6 – April 22, 2002 Issue
CEO SUMMARY: Once again, Ken Freeman and Quest Diagnostics Incorporated is altering the national market for clinical laboratory testing. By acquiring American Medical Laboratories and Unilab, the nation’s largest lab company is expanding its presence in California, Nevada, and Washingto…
First-Ever “Black Belt” Certified In an American Hospital Lab
By Robert Michel | From the Volume IX No. 5 – April 1, 2002 Issue
IT WAS A BIG DEAL in the laboratory of Grant Riverside Hospital of Columbus, Ohio when Lab Site Manager Sandra Hood received her certification as a Six Sigma Black Belt on January 23, 2002. That’s because hospital administrators had selected the laboratory to be hospital’s guine…
NYC Lab Hand-Entered Reqs After Terrorist Acts
By Robert Michel | From the Volume VIII No. 14 – October 15, 2001 Issue
CEO SUMMARY: Crisis management was the watchword at Centralized Laboratory Services, Inc. of New York City following the terrorist attacks on September 11. Damage around the World Trade Center knocked out the communications link between the lab and a data server which transmitted electron…
It’s Modular Automation At Beaumont Hospital Lab
By Robert Michel | From the Volume VIII No. 12 – September 4, 2001 Issue
CEO SUMMARY: Many hospital labs are evaluating laboratory automation options. The fastest-growing problem which needs an answer is the shortage of trained medical technologists and technicians. At William Beaumont Hospital’s new laboratory, selective workstation and modular automation s…
Of Automation, the Internet, and Other Curiosities
By R. Lewis Dark | From the Volume VIII No. 12 – September 4, 2001 Issue
IN READING THE FIRST DRAFTS of the stories in this issue of THE DARK REPORT, I was struck by the unsteady progress that’s been made in the lab industry by emerging technologies such as total laboratory automation (TLA) and Internet-based lab services during recent years. How many of us remember th…
Specialty Labs Prepares For Public Stock Offering
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: Stock prices for public lab companies zoomed upwards through 2000. For this reason, executives at Specialty Laboratories, Inc. believe it is an auspicious time for their laboratory to bring an initial public offering (IPO) to market. Company officials recently filed a stock r…
Accurate Costing of New Pap Technology Proves Interesting
By Robert Michel | From the Volume VII No. 13 – September 11, 2000 Issue
CEO SUMMARY: Various new technologies intended to supplant conventional Pap smear screening must deliver improved clinical performance in a cost-effective manner. Joseph Plandowski, our guest writer,concludes his three-part series on new Pap smear technologies by evaluating actual lab cos…
Genesis Clinical Laboratory Hits Outreach Home Run
By Robert Michel | From the Volume VII No. 12 – August 21, 2000 Issue
CEO SUMMARY: Commercial laboratory consolidation has left Chicago with only a handful of laboratory providers. New management at MacNeal Hospital’s for-profit laboratory division recognized this opportunity. During the past three years, the outreach program was revitalized and the sales…
Qualigen’s POL PSA Test Cleared for Sale by FDA
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Qualigen, Inc. gained FDA approval to sell its FastPack™ System for PSA testing in the United States. Qualigen is one more example of a technology company that expects to shift diagnostic testing out of core laboratories and closer to the patient. Initially Qualigen will se…
War College Identifies Emerging Lab Trends
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
CEO SUMMARY: Disruptive technologies and the arrival of healthcare E-commerce were two common themes which emerged from this year’s Executive War College on Laboratory and Pathology Management. Consensus by faculty and attendees alike was that every lab organization should have an Inter…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized